It has been reported that MLH1 polymorphisms correlate with the pathogenesis of colorectal cancer, lung cancer, breast cancer, prostate cancer, head and neck squamous cell carcinoma, and oral squamous cell carcinoma29–36. Here, MLH1 is linked to prostate cancer.